Search

Your search keyword '"Tewari-Singh N"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Tewari-Singh N" Remove constraint Author: "Tewari-Singh N"
59 results on '"Tewari-Singh N"'

Search Results

7. Chloropicrin induced ocular injury: Biomarkers, potential mechanisms, and treatments.

8. Dexamethasone targets actin cytoskeleton signaling and inflammatory mediators to reverse sulfur mustard-induced toxicity in rabbit corneas.

9. Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models.

10. Nitrogen Mustard-Induced Ex Vivo Human Cornea Injury Model and Therapeutic Intervention by Dexamethasone.

11. Establishing a Dexamethasone Treatment Regimen To Alleviate Sulfur Mustard-Induced Corneal Injuries in a Rabbit Model.

12. Metabolomics for identifying pathways involved in vesicating agent lewisite-induced corneal injury.

13. Ocular injury progression and cornea histopathology from chloropicrin vapor exposure: Relevant clinical biomarkers in mice.

14. Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model.

15. A review of chemical warfare agents linked to respiratory and neurological effects experienced in Gulf War Illness.

16. Mast Cells Promote Nitrogen Mustard-Mediated Toxicity in the Lung Associated With Proinflammatory Cytokine and Bioactive Lipid Mediator Production.

17. Pathophysiology and inflammatory biomarkers of sulfur mustard-induced corneal injury in rabbits.

18. Effect of supersaturated oxygen emulsion treatment on chloropicrin-induced chemical injury in ex vivo rabbit cornea.

20. Phosgene oxime: a highly toxic urticant and emerging chemical threat.

21. Toxic consequences and oxidative protein carbonylation from chloropicrin exposure in human corneal epithelial cells.

22. A Supersaturated Oxygen Emulsion for the Topical Treatment of Ocular Trauma.

23. Acute corneal injury in rabbits following nitrogen mustard ocular exposure.

24. Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.

25. Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea.

26. Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.

27. Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity.

28. Clinical progression of ocular injury following arsenical vesicant lewisite exposure.

29. Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.

30. Corneal toxicity induced by vesicating agents and effective treatment options.

31. Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization.

32. Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.

33. Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.

34. Topical nitrogen mustard exposure causes systemic toxic effects in mice.

35. Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.

36. Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries.

37. Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes.

38. Histopathological and immunohistochemical evaluation of nitrogen mustard-induced cutaneous effects in SKH-1 hairless and C57BL/6 mice.

39. Cutaneous injury-related structural changes and their progression following topical nitrogen mustard exposure in hairless and haired mice.

40. Absence of a p53 allele delays nitrogen mustard-induced early apoptosis and inflammation of murine skin.

41. Clinically-relevant cutaneous lesions by nitrogen mustard: useful biomarkers of vesicants skin injury in SKH-1 hairless and C57BL/6 mice.

42. Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

43. Silibinin attenuates sulfur mustard analog-induced skin injury by targeting multiple pathways connecting oxidative stress and inflammation.

44. Mechanisms of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced DNA damage in skin epidermal cells and fibroblasts.

45. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin.

46. 2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin.

47. Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo.

48. Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathway.

49. Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice.

50. Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice.

Catalog

Books, media, physical & digital resources